Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Does glatiramer acetate provoke hepatitis in multiple sclerosis?
Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] (RECYCLINE)
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.
Slowing of brain atrophy and reductions in new multiple sclerosis lesions sustained at three years in patients treated with Genzyme's LemtradaTM
Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis.
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
Innovation at RUSH
Ginseng in the Treatment of Fatigue in Multiple Sclerosis: A Randomized Placebo-Controlled Double-Blind Pilot Study.
MYRAC Rx
Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.
Neuromyelitis optica with very late onset.
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
CD46: The 'multitasker' of complement proteins.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.
A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.
Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases
Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
Regional Cervical Cord Atrophy and Disability in Multiple Sclerosis: A Voxel-based Analysis.
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity.
Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
MS and NMO: Partners No More.

Pages